Report
EUR 236.14 For Business Accounts Only

Dying profitability

The revenues dropped by 11.09% to JOD5.26M over the 1st half of 2015. The profitability is still struggling, despite a slight improvement in the gross margin, with heavier losses of JOD6.1M compared to JOD-5.7M in H1 2014. The net margin is up -115.9%. No significant moves on investments or debts are reported.
Underlying
Jordanian Pharmaceutical Manufacturing

Provider
AlphaMena Corporate Services
AlphaMena Corporate Services

AlphaMena is the MENA stocks leader in independent equity research, covering 142. MENA securities spanning across 19 sectors and 8 countries relaying on a team of 11 analysts. The breadth of coverage allows AlphaMena to formulate a coherent view on markets, sectors and to highlight the best investments in Mena zone using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.

Other Reports on these Companies
Other Reports from AlphaMena Corporate Services

ResearchPool Subscriptions

Get the most out of your insights

Get in touch